Biomerica (BMRA) Payables (2011 - 2026)
Biomerica (BMRA) reported Payables of $730000.0 for Q1 2026, up 15.51% on a YoY basis from $632000.0 in Q1 2025, and down 1.35% sequentially from $740000.0 in Q4 2025.
Biomerica (BMRA) Payables (2011 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Payables data on file, last reported at $730000.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 15.51% year-over-year to $730000.0; the trailing twelve-month figure through Feb 2026 stood at $730000.0 (up 15.51% YoY), and the FY2025 full-year result was $672000.0, down 40.95% from the prior year.
- Payables eased to $730000.0 in Q1 2026, from $740000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $2.6 million in Q1 2022 to a low of $344000.0 in Q2 2023.
- A 5-year average of $856728.4 and a median of $730000.0 in 2026 frame the typical range for Payables.
- Across the five-year window, Payables jumped 245.02% in 2022 and plunged 85.16% in 2023, its largest moves.
- Tracing BMRA's Payables over 5 years: stood at $670074.0 in 2022, then grew by 16.85% to $783000.0 in 2023, then rose by 8.3% to $848000.0 in 2024, then decreased by 12.74% to $740000.0 in 2025, then slipped by 1.35% to $730000.0 in 2026.
- Business Quant data shows BMRA's Payables at $730000.0 in Q1 2026, $740000.0 in Q4 2025, and $681000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 5.78 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.93 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.39 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.42 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 730,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 730,000.00 |
| Nov 30, 2025 | 740,000.00 |
| Aug 31, 2025 | 681,000.00 |
| May 31, 2025 | 672,000.00 |
| Feb 28, 2025 | 632,000.00 |
| Nov 30, 2024 | 848,000.00 |
| Aug 31, 2024 | 1.09 Mn |
| May 31, 2024 | 1.14 Mn |
| Feb 29, 2024 | 885,000.00 |
| Nov 30, 2023 | 783,000.00 |
| Aug 31, 2023 | 713,000.00 |
| May 31, 2023 | 344,000.00 |
| Feb 28, 2023 | 387,228.00 |
| Nov 30, 2022 | 670,074.00 |
| Aug 31, 2022 | 671,240.00 |
| May 31, 2022 | 972,000.00 |
| Feb 28, 2022 | 2.61 Mn |
| Nov 30, 2021 | 1.58 Mn |
| Aug 31, 2021 | 641,404.00 |
| May 31, 2021 | 583,380.00 |